SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
momo-T/FIF
An SI Board Since October 2003
Posts SubjectMarks Bans
12215 138 0
Emcee:  scaram(o)uche Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
11065PIRS P1 against hepcidin was a single ascending dose trial. No repeat dosingtuck-3/6/2017
11064>> forgot, I actually sold PIRS a few days ago << Nice to know thatscaram(o)uche-3/6/2017
11063>> what am I missing as to the bear case? << I don't have a cluscaram(o)uche-3/6/2017
11062ooooomph!scaram(o)uche-3/6/2017
11061Looks decent ? GHENT, Belgium, 6 March 2017 - Ablynx [Euronext Brusselnigel bates-3/6/2017
11060TGTX: I was tempted to sell when it hit double digits. With no OS data, I wondetuck-3/6/2017
11059I spent the day watching, buying and trading some TGTX on their important news. Biotech Jim-3/6/2017
11058PRS-343 at AACR: >>3673 / 16 - Preclinical toxicology and pharmacology fotuck13/6/2017
11057Who put me onto auph? PGS? Strange and often not wonderful trip to date, but ascaram(o)uche-3/1/2017
11056More results on Omeros 721 Phase 2 study of treatment of hematopoietic stem cellD.Lu13/1/2017
11055RE:MGNX 4Q CC progress on many programs, but no "headline news". May bMiljenko Zuanic-3/1/2017
11054Today, on many issue volume was small to account big bets on coming upside for bMiljenko Zuanic12/27/2017
11053This was first steady up up up day in a while. In front of speech. Surprising. GRobohogs-2/27/2017
11052JUNO, or any other....anything can happen tomorrow. I am hedging today gains,...Miljenko Zuanic-2/27/2017
11051CARA again... The few shares sold in the post to which I am replying, added witBiotech Jim12/27/2017
11050JUNO is long term play, in parallel to KITE. It may be good bet, and it may not?Miljenko Zuanic-2/24/2017
11049Re JUNO <Do you see near term catalysts?> No, buying for the long haul aBiotech Jim-2/24/2017
11048Both you and Miljenko are interested in JUNO versus KITE (which has been a greattuck-2/24/2017
11047Started a position in JUNO this morning. I plan to buy in several tranches overBiotech Jim-2/24/2017
11046Promising research for antivirals: Genomic RNA folding mediates assembly of humanigel bates-2/24/2017
11045>> delaying effector T-cell differentiation and exhaustion << And ascaram(o)uche-2/23/2017
11044Shows that Juno is working on their next generation of CRISPR made CAR-T cell thidos-2/23/2017
11043Interesting for JUNO ? nature.comnigel bates-2/22/2017
11042<Do you or anyone else have thoughts on 845"s launch performance?> IBiotech Jim-2/22/2017
11041and Miller's rationale is rampant.... usnews.com MASSACHUSETTS NEWS The Lascaram(o)uche-2/13/2017
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News